Commonwealth Equity Services, LLC Dexcom Inc Transaction History

Commonwealth Equity Services, LLC

$60.2 Billion
Q1 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 52,116 shares of DXCM stock, worth $5.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

52,116

Previous 47,405 9.94%

Holding current value

$5.78 Million

Previous $5.88 Million 22.88%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$114.22 - $140.1 $538,090 - $660,011	4,711 Added 9.94%	52,116 $7.23 Million
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $274,481 - $451,445	3,636 Added 8.31%	47,405 $5.88 Million
Q3 2023 Oct 23, 2023	BUY	$86.06 - $137.93 $54,648 - $87,585	635 Added 1.47%	43,769 $4.08 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $889,075 - $1.04 Million	7,905 Added 22.44%	43,134 $5.54 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $358,904 - $424,196	-3,451 Reduced 8.92%	35,229 $4.09 Million

Q4 2022 Feb 07, 2023	SELL	$84.98 - $122.67 $23,539 - $33,979	-277 Reduced 0.71%	38,680 $4.38 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $134,146 - $165,474	-1,757 Reduced 4.32%	38,957 $3.14 Million
Q2 2022 Jul 19, 2022	BUY	$67.99 - $132.89 $2.14 Million - $4.17 Million	31,412 Added 337.69%	40,714 $3.03 Million
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $217,136 - $300,501	-2,308 Reduced 19.88%	9,302 $4.76 Million
Q4 2021 Jan 31, 2022	SELL	$129.87 - $162.82 $59,480 - $74,571	-458 Reduced 3.8%	11,610 $6.23 Million
Q3 2021 Oct 29, 2021	BUY	$106.71 - $143.18 $365,695 - $490,677	3,427 Added 39.66%	12,068 $6.6 Million
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $3,563 - $4,748	44 Added 0.51%	8,641 $3.69 Million
Q1 2021 May 04, 2021	SELL	$84.79 - $104.74 $88,435 - $109,243	-1,043 Reduced 10.82%	8,597 $3.09 Million
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $491,322 - $658,245	-6,299 Reduced 39.52%	9,640 $3.56 Million
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $647,653 - $765,913	6,781 Added 74.04%	15,939 $6.57 Million
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $115,958 - $194,879	1,850 Added 25.31%	9,158 $3.71 Million
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $65,806 - $104,142	1,377 Added 23.22%	7,308 $1.97 Million
Q4 2019 Feb 05, 2020	BUY	$36.62 - $57.29 $2,783 - $4,354	76 Added 1.3%	5,931 $1.3 Million
Q3 2019 Oct 30, 2019	BUY	$35.53 - $43.8 $7,603 - $9,373	214 Added 3.79%	5,855 $873,000
Q2 2019 Jul 19, 2019	BUY	$27.84 - $38.92 $46,993 - $65,696	1,688 Added 42.7%	5,641 $845,000
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $14,231 - $19,357	507 Added 14.71%	3,953 $470,000
Q4 2018 Feb 11, 2019	SELL	$26.99 - $37.37 $30,849 - $42,713	-1,143 Reduced 24.91%	3,446 $412,000
Q3 2018 Nov 06, 2018	BUY	$23.35 - $36.72 $50,109 - $78,801	2,146 Added 87.84%	4,589 $656,000
Q2 2018 Jul 31, 2018	BUY	$17.54 - $25.22 $42,850 - $61,612	2,443 New	2,443 $232,000

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $42.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Dexcom Inc Transaction History